All stock lists
Unlock the score
Tyra Biosciences, Inc. (TYRA)
United States · Delayed Price · Currency is USD
Pharmaceutical Preparations
20.70+0.25 (+1.20%)
Insider Score
Insider Score
/ 100
TYRA Insider Score
Tyra Biosciences, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
TYRA Stock Insider Trading Activity
TYRA stock’s insider trading shows 1 purchase for an estimated $20.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days1 qualifying buy1 insider$20.00K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Harris Todd CEO | Award | 864 | $9.13 | $7.89K | 0.1% | 1,438,495 | Sep 15, 2026 | — | Form 4 |
| Fuhrman Alan CFO | Award | 951 | $9.13 | $8.68K | 2.6% | 37,115 | Sep 15, 2026 | — | Form 4 |
| Rueb Yuliya Other | Award | 2,925 | $9.13 | $26.70K | 35.1% | 11,258 | Sep 15, 2026 | — | Form 4 |
| Verjee Rehan Director | Buy | 972 | $20.58 | $20.00K | New | 972 | Sep 9, 2026 | BFirst BuyDilution | Form 4 |
| Ashar Bhavesh COO | Award | 15,013 | — | — | New | 15,013 | May 5, 2026 | — | Form 4 |
| Rueb Yuliya Other | Award | 8,333 | — | — | 23.8% | 43,354 | May 5, 2026 | — | Form 4 |
| Harris Todd CEO | Award | 79,000 | — | — | 5.8% | 1,437,631 | May 5, 2026 | — | Form 4 |
| Fuhrman Alan CFO | Award | 20,000 | — | — | 124% | 36,164 | May 5, 2026 | — | Form 4 |
| Warner Douglas J Other | Award | 25,000 | — | — | New | 25,000 | May 5, 2026 | — | Form 4 |
| KAPLAN GILLA Director | Option exercise | 53,172 | $2.25 | $119.64K | 39.5% | 81,403 | Mar 26, 2026 | — | Form 4 |
| KAPLAN GILLA Director | To issuer | 53,172 | $37.75 | $2.01M | 65.3% | 28,231 | Mar 26, 2026 | — | Form 4 |
| KAPLAN GILLA Director | Option exercise | 14,295 | $2.25 | $32.16K | 50.6% | 42,526 | Mar 25, 2026 | — | Form 4 |
| KAPLAN GILLA Director | Sell | 14,295 | $36.97 | $528.49K | 33.6% | 28,231 | Mar 25, 2026 | — | Form 4 |
| Fuhrman Alan CFO | Award | 1,376 | $9.13 | $12.56K | 9.3% | 16,164 | Mar 13, 2026 | — | Form 4 |
| Harris Todd CEO | Award | 1,463 | $9.13 | $13.36K | 0.1% | 1,358,631 | Mar 13, 2026 | — | Form 4 |
| Bensen Daniel Other | Sell | 2,128 | $31.50 | $67.03K | 1.4% | 152,853 | Feb 12, 2026 | — | Form 4 |
| Bensen Daniel Other | Sell | 5,872 | $33.37 | $195.95K | 3.8% | 146,981 | Feb 12, 2026 | — | Form 4 |
| Bensen Daniel Other | Sell | 1,017 | $29.08 | $29.57K | 0.7% | 154,981 | Jan 12, 2026 | — | Form 4 |
| Bensen Daniel Other | Sell | 6,983 | $28.44 | $198.60K | 4.3% | 155,998 | Jan 12, 2026 | — | Form 4 |
| MORE ROBERT J Director | Sell | 10,000 | $25.00 | $250.00K | 0.3% | 3,823,425 | Dec 19, 2025 | — | Form 4 |
| Bensen Daniel Other | Sell | 8,000 | $22.64 | $181.12K | 4.7% | 162,981 | Dec 12, 2025 | — | Form 4 |
| MORE ROBERT J Director | Sell | 246,871 | $20.25 | $5.00M | 6.1% | 3,833,425 | Nov 21, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 49,956 | $16.32 | $815.28K | 22.6% | 170,981 | Nov 19, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 75,633 | $16.07 | $1.22M | 25.5% | 220,937 | Nov 18, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 18,572 | $16.11 | $299.19K | 5.9% | 298,070 | Nov 17, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 1,500 | $17.07 | $25.61K | 0.5% | 296,570 | Nov 17, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 110,228 | $16.02 | $1.77M | 25.8% | 316,642 | Nov 14, 2025 | — | Form 4 |
| Bensen Daniel COO | Sell | 1,111 | $16.00 | $17.78K | 0.3% | 426,870 | Nov 13, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- To issuer (D) — Shares returned or sold back to the company
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.